Please provide your email address to receive an email when new articles are posted on . Visual acuity at distances of 0.3 m, 0.5 m and 0.7 m significantly improved. Users experienced higher ...

The Companies plan to file an application with the FDA in the second half of 2025. Topline data were announced from a phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) for the ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

There were 26 serious adverse events in 19 participants; 21 (81%) occurred within 2 months after surgery. HealthDay News — In participants with geographic atrophy due to age-related macular ...